BioFactors
PAF‐induced inflammatory and immuno‐allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects
BioFactors, Volume 48, Issue 6, Page 1226-1249, November/December 2022.
BioFactors
Carboxylative efficacy of trans and cis MK7 and comparison with other vitamin K isomers
BioFactors, Volume 48, Issue 5, Page 1129-1136, September/October 2022.
BioFactors
HDL‐mediated reduction of cholesterol content inhibits the proliferation of prostate cancer cells induced by LDL: Role of ABCA1 and proteasome inhibition
BioFactors, Volume 48, Issue 3, Page 707-717, May/June 2022.
BioFactors
Selective inhibition of phosphodiesterase 4D increases tau phosphorylation at Ser214 residue
BioFactors, Volume 48, Issue 5, Page 1111-1117, September/October 2022.
BioFactors
Experimental and clinical evidence on the effect of carvacrol on respiratory, allergic, and immunologic disorders: A comprehensive review
BioFactors, Volume 48, Issue 4, Page 779-794, July/August 2022.
BioFactors
Docosahexaenoic acid may inhibit immune evasion of colorectal cancer cells through targeting immune checkpoint and immunomodulator genes and their controlling microRNAs
BioFactors, Volume 48, Issue 5, Page 1137-1144, September/October 2022.
BioFactors
Lipid bilayer composition as a determinant of cancer cell sensitivity to tumoricidal protein‐lipid complexes
BioFactors, Volume 48, Issue 5, Page 1145-1159, September/October 2022.
BioFactors
Maternal erythrocyte fatty acid composition as a predictive marker for pregnancy health
BioFactors, Volume 48, Issue 4, Page 763-778, July/August 2022.